Newer anticoagulants in cardiovascular disease: a systematic review of the literature.

Abstract:

:Vitamin K antagonists (VKAs) such as warfarin have traditionally been the major therapeutic option for anticoagulation in clinical practice. VKAs are effective and extensively recommended for the prevention of venous and arterial thromboembolism in cardiovascular disease. Despite its effectiveness, warfarin is limited by factors such as a narrow therapeutic index, drug-drug interactions, food interactions, slow onset and offset of action, hemorrhage, and routine anticoagulation monitoring to maintain therapeutic international normalized ratio. During the last 2 decades, the approval of anticoagulants, such as low-molecular-weight heparins, indirect factor Xa inhibitors (eg, fondaparinux), and direct thrombin inhibitors (eg, argatroban, lepirudin, and desirudin), have expanded the number of available antithrombotic compounds with additional targets within the anticoagulation pathway. Although these medications offer several potential therapeutic advantages, they all require parenteral or subcutaneous administration and are substantially more expensive than VKAs. Thus, VKAs, despite several limitations, have remained the major option for most patients requiring chronic anticoagulation. These limitations have prompted interest in the development of newer oral anticoagulants. Novel anticoagulants targeting inhibition of factor Xa and thrombin (factor IIa) have now been incorporated into clinical practice based on the results of large randomized clinical trials, with the recent U.S. Food and Drug Administration approval of dabigatran for stroke prevention in atrial fibrillation and rivaroxaban for deep vein thrombosis and stroke prevention in atrial fibrillation, with multiple other agents in various stages of development for these and other indications. This review discusses the pharmacological properties, clinical results, and therapeutic applications of novel and new anticoagulants, thereby providing an outline for the future of anticoagulation in cardiovascular disease.

journal_name

Cardiol Rev

journal_title

Cardiology in review

authors

Maan A,Padmanabhan R,Shaikh AY,Mansour M,Ruskin JN,Heist EK

doi

10.1097/CRD.0b013e3182503e2d

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

209-21

issue

5

eissn

1061-5377

issn

1538-4683

journal_volume

20

pub_type

杂志文章,评审
  • Cardiac rupture after myocardial infarction: new insights from murine models.

    abstract::Cardiac rupture after a myocardial infarction is an uncommon event with devastating consequences. Although the clinical features of rupture have been described, the genetic and molecular influences on this outcome in patients are less certain. In mice, at least 17 genetic models have been developed that enhance or sup...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181bf4ab4

    authors: Sane DC,Mozingo WS,Becker RC

    更新日期:2009-11-01 00:00:00

  • Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

    abstract::Mechanical valve thrombosis is a life-threatening event. Pregnancy is associated with a hypercoagulable state that further emphasizes the importance of adequate anticoagulation. This is associated with a therapeutic dilemma. Continued anticoagulation with warfarin throughout the first trimester can result in fetopathi...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-200211000-00007

    authors: Behrendt P,Schwartzkopff B,Perings S,Gerhardt A,Zotz RB,Strauer BE

    更新日期:2002-11-01 00:00:00

  • Social and Psychologic Aspects of Coronary Heart Disease in Women.

    abstract::This literature review examines the association of social and psychologic characteristics among women with a) the risk of developing coronary heart disease and b) prognosis and recovery after disease has become manifest. Studies of psychosocial risk factors are often conflicting. These divergent findings can result fr...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:

    authors: Eaker ED

    更新日期:1998-05-01 00:00:00

  • Pulmonary arterial hypertension and women.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disorder with a poor prognosis. It is characterized by sustained elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). It is defined hemodynamically by a mean PAP over 25 mm Hg, a pulmonary arterial wedge pressure of 15 mm Hg or les...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000240529.49704.2e

    authors: De Marco T

    更新日期:2006-11-01 00:00:00

  • Tc-99m tetrofosmin reverse perfusion pattern with ST segment depression after dipyridamole infusion in a patient with unstable angina and no evident coronary artery stenoses.

    abstract::Reverse redistribution is a well-known pattern found when performing thallium myocardial scintigraphy, and it has been implicated as an indicator of myocardial ischemia. Much more rarely, when using technetium compounds, which do not redistribute, a similar pattern is noted after the second injection of the radiotrace...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000115927.76990.25

    authors: Antonopoulos A,Galanopoulou K,Katsafados I,Siantos E

    更新日期:2004-05-01 00:00:00

  • Heart Failure With Preserved Ejection Fraction: What Is in a Name?

    abstract::Evidence-based management of heart failure (HF) with preserved left ventricular ejection fraction (LVEF; HFpEF) remains a major gap in the care of patients with HF. Clinical trials directed toward the population with HFpEF have been disappointing, although renin-angiotensin-aldosterone system blockade appears to preve...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000057

    authors: Jumean MF,Konstam MA

    更新日期:2015-07-01 00:00:00

  • Radiation-induced heart disease.

    abstract::Radiation-induced heart disease (RIHD) is becoming an increasing concern for patients and clinicians alike as the use of radiation therapy for the treatment of certain malignancies increases, and patient mortality secondary to neoplasms of the thorax, in particular Hodgkin's lymphoma and breast cancer, decreases. The ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182431c23

    authors: Filopei J,Frishman W

    更新日期:2012-07-01 00:00:00

  • Reverse Remodeling in Systolic Heart Failure.

    abstract::Left ventricular (LV) remodeling is the most common term used to describe the functional, structural, myocellular, and interstitial changes that occur in response to myocardial injury and/or chronic changes in myocardial loading conditions. Progression of LV remodeling over time in response to neurohormonal activation...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000068

    authors: Saraon T,Katz SD

    更新日期:2015-07-01 00:00:00

  • A novel approach to left atrial appendage exclusion: the WATCHMAN device.

    abstract::Atrial fibrillation (AF), a very common cardiac arrhythmia, is a well-recognized predisposing factor for embolic stroke. While warfarin remains the cornerstone of anticoagulant treatment in patients with AF, it is often underutilized because of increased bleeding complications and frequent monitoring requirements. It ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181e53abb

    authors: Gorodnitskiy A,Lucariello RJ,Aizer A,Coppola JT

    更新日期:2010-09-01 00:00:00

  • Gender differences and the outcome of interventions for acute coronary syndromes.

    abstract::Differences in the overall mortality for acute infarction in women vs men have been appreciated for some time. Some of these differences are based on the age at the time of presentation of women compared with men. Excess mortality in women is most clear at the younger end of the age spectrum. More careful examination ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008040-00009

    authors: Feldman T,Silver R

    更新日期:2000-07-01 00:00:00

  • Left Ventricular Noncompaction: Diagnostic Approach, Prognostic Evaluation, and Management Strategies.

    abstract::Left ventricular noncompaction cardiomyopathy is a heart disease with relevant potential complications including heart failure, life-threatening arrhythmias, and embolic events. In order to prevent adverse outcomes, it is crucial to appropriately recognize and manage this cardiomyopathy. In this paper, we report the m...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000251

    authors: Di Fusco SA,Lucà F,Madeo A,Massimiliano Rao C,Iorio A,Rizzo M,Dalila Luisella Delcre S,Colivicchi F,Gabrielli D,Paolo Pino G,Massimo Gulizia M

    更新日期:2020-05-01 00:00:00

  • Coronary artery rupture associated with amphetamine abuse.

    abstract::We report a case of spontaneous coronary artery rupture associated with amphetamine abuse in a 31-year-old woman. The patient presented to the emergency department with sudden onset of central chest pain and a normal electrocardiogram. Cardiac enzymes were consistent with acute myocardial infarction. Drug screening wa...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000132372.38506.45

    authors: Brennan K,Shurmur S,Elhendy A

    更新日期:2004-09-01 00:00:00

  • Endothelin as a clinical target in the treatment of systemic hypertension.

    abstract::Endothelin is a potent vasoconstrictor substance that also can exert proliferative, inflammatory, and fibrotic changes in blood vessels and other organs. It acts on tissues in a paracrine and autocrine fashion, with local production and regulation occurring in both endothelial and nonendothelial cells. Endothelin stim...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181aa8f4a

    authors: Prasad VS,Palaniswamy C,Frishman WH

    更新日期:2009-07-01 00:00:00

  • Relaxin: a new approach for the treatment of acute congestive heart failure.

    abstract::Relaxin, a naturally-occurring hormone in the insulin family, was discovered to have a physiologic role in pregnancy. Named initially for its relaxing effect on the pubic ligament, relaxin receptors have since been found to be widely distributed in many organs in both males and females. Acting through multiple pathway...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181f493e3

    authors: Grossman J,Frishman WH

    更新日期:2010-11-01 00:00:00

  • The Sexual Dimorphism of High Blood Pressure.

    abstract::There is a sexual dimorphism in blood pressure: men tend to have higher blood pressures than women with functional ovaries, whereas ovariectomy or menopause tends to abolish the sexual dimorphism and cause women to develop a "male" pattern of blood pressure. Synthetic estrogens and progestins, found in oral contracept...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/00045415-199811000-00012

    authors: Calhoun DA,Oparil S

    更新日期:1998-11-01 00:00:00

  • Epigenetic regulation in heart failure: part II DNA and chromatin.

    abstract::Epigenetic regulatory mechanisms play key roles in cardiac development, differentiation, homeostasis, response to stress and injury, and disease. Human heart failure (HF) epigenetic regulatory mechanisms have not been deciphered to date. This 2-part review distills the rapidly evolving research focused on human HF epi...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000074

    authors: DiSalvo TG

    更新日期:2015-11-01 00:00:00

  • Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

    abstract::The increased life expectancy of women living in industrialized countries is associated with an increase in diseases dependent or facilitated by a state of estrogen deficiency, such as cardiovascular and cerebrovascular diseases. Several studies have shown that estrogen replacement therapy reduces the occurrence of co...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200201000-00010

    authors: Rosano GM,Fini M

    更新日期:2002-01-01 00:00:00

  • Ticagrelor: a novel reversible oral antiplatelet agent.

    abstract::The complex mechanism of platelet activation creates an optimal target for pharmacological treatment in patients with acute coronary syndromes. Current antiplatelet medications that are used in addition to aspirin include the thienopyridines, clopidogrel and prasugrel, but there are several limitations to the use of t...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182099d86

    authors: Nawarskas JJ,Clark SM

    更新日期:2011-03-01 00:00:00

  • Pacemakers and store security devices.

    abstract::The ever-increasing complexity of medical device therapy and installation of public electronic security systems demands vigilance in discerning interactions that may be harmful to patients during typical activities of daily living. Premature pacemaker stimulation, isolated skipped beats, or reversion to backup asynchr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200101000-00004

    authors: Harthorne JW

    更新日期:2001-01-01 00:00:00

  • Pharmacotherapeutic management of pulmonary arterial hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a disabling chronic disorder of the pulmonary vasculature, which is characterized by increased pulmonary artery pressure as a result of increased pulmonary vascular resistance. The pathology of PAH is characterized by pulmonary vascular vasoconstriction, smooth muscle cell prol...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181d4e921

    authors: Anderson JR,Nawarskas JJ

    更新日期:2010-05-01 00:00:00

  • Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit.

    abstract::Evacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that has been recently studied as a cholesterol modifying agent to reduce cardiovascular risk and mortality in high risk cardiovascular disease patients. Evacetrapib acts to decrease lipid exchange through CETP inhibition. CETP acts to transfer chole...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000137

    authors: Eyvazian VA,Frishman WH

    更新日期:2017-03-01 00:00:00

  • Myocardial viability and microvascular obstruction: role of cardiac magnetic resonance imaging.

    abstract::Established coronary artery disease has a prevalence of 7% in adult Americans, accounting for 16 million people. As morbidity and mortality rates have risen, research efforts to identify the pathophysiologic mechanisms of systolic dysfunction have risen in parallel. The current goal is to develop new therapeutic strat...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000024

    authors: Romero J,Lupercio F,Haramati LB,Garcia MJ,Lucariello RJ

    更新日期:2014-09-01 00:00:00

  • Association between Arsenic Exposure and Cardiovascular Disease.

    abstract::Arsenic is a ubiquitously dispersed metalloid that has been implicated as the cause of various adverse health effects. Human exposure to arsenic primarily occurs through contaminated drinking water and dietary intake of rice and grains, posing a great public health risk to millions of people worldwide. High levels of ...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0000000000000357

    authors: Kononenko M,Frishman WH

    更新日期:2020-09-15 00:00:00

  • A Review of Remdesivir for COVID-19: Data to Date.

    abstract::Severe acute respiratory coronavirus-2 (SARS-CoV-2) is responsible for one of the greatest public health challenges of our lifetime, the coronavirus disease 2019 (COVID-19) pandemic. Because of the complicated postinfection sequelae and grave consequences, the search for effective therapies has become a worldwide prio...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000337

    authors: Mehta M,Shyh GI

    更新日期:2020-11-01 00:00:00

  • The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.

    abstract::A decision-tree analysis was used to estimate the average cost per patient using the direct thrombin inhibitor argatroban for early treatment (<48 hours after thrombocytopenia onset) compared with delayed treatment (> or =48 hours after thrombocytopenia onset) of immune-mediated heparin-induced thrombocytopenia (HIT) ...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000164011.17381.6f

    authors: Arnold RJ,Kim R,Tang B

    更新日期:2006-01-01 00:00:00

  • Cardiac Resynchronization Therapy: Maximizing the Response to Biventricular Pacing.

    abstract::Cardiac resynchronization therapy (CRT) has become a mainstay therapy to improve clinical outcomes of patients with left ventricular systolic dysfunction and a wide QRS complex, in addition to guideline-directed medical therapy. As clinical experience with CRT continues to expand, the device and lead design, along wit...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000127

    authors: Ng CY,Heist EK

    更新日期:2017-01-01 00:00:00

  • Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?

    abstract::There is growing evidence that inflammatory processes may be involved in the development of atherosclerosis and its complications. Viral and bacterial pathogens have been implicated as possible causative factors in the pathogenesis of coronary artery disease and postangioplasty restenosis. Antibiotic trials have been ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200207000-00004

    authors: Frishman WH,Ismail AA

    更新日期:2002-07-01 00:00:00

  • Evaluation of the Emergency Department chest pain patient.

    abstract::Patients presenting to the Emergency Department with chest pain are common and often present diagnostic difficulties. Because of the limitations of the initial evaluation, the majority of patients are admitted, although many are later found to have noncardiac causes for their symptoms. Recognition of these limitations...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200109000-00006

    authors: Kontos MC

    更新日期:2001-09-01 00:00:00

  • Gender differences in treatment of heart failure and acute myocardial infarction: a question of quality or epidemiology?

    abstract::Recent articles have inquired about the quality of care for women presenting with cardiovascular disease. The Cooperative Cardiovascular Project and the National Heart Failure Project, 2 Medicare databases, provide national data to address concerns that women receive poorer quality care than men. In these databases, s...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000194093.53005.f0

    authors: Gold LD,Krumholz HM

    更新日期:2006-07-01 00:00:00

  • Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation.

    abstract::Atrial fibrillation (AF) is an independent risk factor for ischemic stroke occurrence, severity, recurrence, and mortality. Anticoagulation therapy for the prevention of thromboembolism is critical in patients with AF who are at risk of stroke. Warfarin has been an efficacious anticoagulant for this purpose, but its u...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0b013e318293d6e6

    authors: Lam S

    更新日期:2013-07-01 00:00:00